Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany

Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany

Abstract Background The PRediction of short-term Outcome in preGNant wOmen with Suspected preeclampsIa Study (PROGNOSIS) demonstrated that a soluble fms-like tyrosine kinase 1/placental growth factor (sFlt-1/PlGF) ratio ≤ 38 ruled out the occurrence of preeclampsia in the next week with a negative p...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Dietmar Schlembach, Martin Hund, Annabel Schroer, Cyrill Wolf
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: BMC 2018-08-01
Cyfres:BMC Health Services Research
Pynciau:
Angiogenic factors
Cost-effectiveness
Cost-saving
Diagnosis
Economic
Diagnosis-related group
Mynediad Ar-lein:http://link.springer.com/article/10.1186/s12913-018-3406-1

Rhyngrwyd

http://link.springer.com/article/10.1186/s12913-018-3406-1

Eitemau Tebyg